BioLucent
	Operator of women\'s health company, involved in the early detection and treatment of breast cancer. The company manufactures and markets the MammoPad breast cushion, a radiolucent foam cushion that breast centers use to provide women with a mammogram.
	['', 'breast cancer', ' ', 'MammoPad breast cushion', ' ', 'radiolucent cushion', '']
Rasiris
	Developer of photodynamic therapy (PDT) and the treatments of breast cancer and age-related macular degeneration. The company received financial support from Pacific Horizon Ventures to validate the proof of concept in an animal model.
	['', 'macular degeneration', ' ', 'breast cancer', ' ', 'photodynamic therapy', '']
RGene Therapeutics
	Developer of gene therapy and other nucleic acid-based drugs. The company intends to develop and commercialize gene therapies for in-vivo approaches to ovarian and breast cancer, an ex-vivo anti-sense treatment for chronic myelogenous leukemia and other applications of its gene and nucleic acid delivery systems.
	['', 'gene therapy', ' ', 'nucleic acid', ' ', 'breast cancer', ' ', 'chronic myelogenous leukemia', '']
Orthotopix
	Developer of modelling products for cancer research. The company is a provider of cell, tissue and animal models modelling the prevention and treatment of breast cancer and prostate cancer, urodynamical models of urethral function and a cell line-based safety model of the endometrium. The company provided its products and services to drug-development companies.
	['', 'drug development', ' ', 'healthcare service', ' ', 'tissue modeling', '']
Endocyte
	Developer of receptor-targeted therapeutics for the treatment of cancer and autoimmune diseases. The company provides EC17, a folate-targeted hapten therapy drug to treat metastatic renal and ovarian cancer; EC145, a folate-targeted chemotherapeutic conjugate to treat various tumors, including cancers of the breast, lung, and blood; EC0225, a targeted chemotherapy drug.
	['', 'cancer treatment', ' ', 'autoimmune disease', ' ', 'ovarian cancer', ' ', 'breast cancer', '']
Seragon Pharmaceuticals
	Developer of orally active selective estrogen receptor degraders (SERDs) that represent a treatment for metastatic breast cancer. The company is developing breast cancer pharmaceuticals based on the selective estrogen receptor degraders platform, including its lead drug candidate, ARN-810, under evaluation for ER+ breast cancer.
	['', 'breast cancer', ' ', 'estrogen receptor degrader', ' metastatic']
Encapsule Medical
	Operator of a medical device company. The company focuses on the development of disposable, non-invasive, breast biopsy devices. Its products include Flash, Halo and Phantom.
	['', 'breast cancer', ' biopsy ', 'breast biopsy', '']
Suomen Terveystutkimus
	Provider of breast-cancer screening products and services. The company develops products and performs mammography screenings along with other clinical tests, to detect and treat breast cancer.
	['', 'breast cancer', ' ', 'mammography screening', ' ', 'cancer treatment', '']
Windy Hill Medical
	Developer of medical devices to reduce the risk of developing breast cancer in high risk patients. The company intends to develop intraductal therapy for the prevention of breast cancer.
	['', 'breast cancer', '']
